Memantine and malaise 
Memantine and malaise Patient Reports February 12, 2012
Memantine Side Effects Report #5827188-X
Memantine side effect was reported by a Health Professional from GERMANY on July 14, 2008. Male patient, 70 years of age, was diagnosed with nystagmus and was treated with Memantine. After drug was administered, patient experienced the following side effects: completed suicide, dizziness
, malaise, myalgia, oscillopsia, quality of life decreased. Memantine dosage: 20 MG (20 MG, 1 IN 12 D), ORAL. During the same period patient was treated with SIMVASTATIN, PERINDOPRIL ERBUMINE. Patient died.Memantine Side Effects Report #5827190-8
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on July 14, 2008. Male patient, 70 years of age, was diagnosed with nystagmus and was treated with Memantine. After drug was administered, patient experienced the following side effects: completed suicide, dizziness
, malaise, myalgia, oscillopsia, quality of life decreased. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SIMVASTATIN, PERINDOPRIL ERBUMINE. Patient died.Memantine Side Effects Report #5717283-8
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 07, 2008. Female patient, 90 years of age, weighting 149.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, dehydration, dementia
, diarrhoea, disease progression, epilepsy , malaise, neutrophil count increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT, FLECAINIDE ACETATE, VIRLIX, EQUANIL, IMOVANE. Patient recovered.Memantine Side Effects Report #4595341-1
Memantine side effect was reported by a Health Professional from on Feb 18, 2005. Female patient, 89 years of age, was diagnosed with dementia alzheimer's type, essential hypertension and was treated with Memantine. After drug was administered, patient experienced the following side effects: difficulty in walking, extrapyramidal disorder, malaise, tremor. Memantine dosage: 5 MG QD PO. During the same period patient was treated with ZESTRIL, ARICEPT. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4480605-2
Memantine side effect was reported by a Health Professional from on Oct 08, 2004. Female patient, 89 years of age, was diagnosed with dementia alzheimer's type, essential hypertension and was treated with Memantine. After drug was administered, patient experienced the following side effects: difficulty in walking, extrapyramidal disorder, malaise, tremor. Memantine dosage: 5 MG QD PO. During the same period patient was treated with ZESTRIL, ARICEPT. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5067183-4
Memantine side effect was reported by a Health Professional from FRANCE on July 10, 2006. Male patient, 88 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, malaise. Memantine dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4848755-6
Memantine side effect was reported by a Health Professional from FRANCE on Nov 24, 2005. Male patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, infection
, malaise, septic shock, transaminases increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with THIORIDAZINE, ASPIRIN, ENALAPRIL MALEATE, AMLODIPINE BESYLATE, NOOTROPYL. Patient recovered.Memantine Side Effects Report #4922744-5
Memantine side effect was reported by a Health Professional from FRANCE on Feb 14, 2006. Male patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, infection
, malaise, septic shock. Memantine dosage: 20 MG QD PO. During the same period patient was treated with THIORIDAZINE, ASPIRIN, ENALAPRIL MALEATE, AMLODIPINE BESYLATE, NOOTROPYL. Patient recovered.Memantine Side Effects Report #5599300-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 03, 2008. Male patient, 82 years of age, weighting 174.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated, depression , dizziness , gait disturbance, malaise, transaminases increased. Memantine dosage: 10 MG QD PO. During the same period patient was treated with PAROXETINE, EQUANIL, ZOPICLONE, TAMSULOSIN. Patient recovered.Memantine Side Effects Report #5736300-2
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2008. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type, hypertension, urinary incontinence
and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood glucose increased, blood urea increased, bradycardia, loss of consciousness, malaise, orthostatic hypotension. Memantine dosage: 10 MG BID PO. During the same period patient was treated with MODUCREN, ARICEPT, TANAKAN, LANSOPRAZOLE, DITROPAN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5775561-0
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on May 29, 2008. Male patient, 81 years of age, was diagnosed with dementia alzheimer's type, prostatic adenoma and was treated with Memantine. After drug was administered, patient experienced the following side effects: atrioventricular block second degree, bradycardia, malaise, syncope. Memantine dosage: unknown. During the same period patient was treated with TAMSULOSIN, CLOPIDOGREL. Patient recovered.
Memantine Side Effects Report #5458193-3
Memantine side effect was reported by a Physician from ARGENTINA on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, varicose vein
. Memantine dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5468659-8
Memantine side effect was reported by a Physician from ARGENTINA on Sept 13, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, dehydration, dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, microcytosis, red blood cell count decreased. Memantine dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5480869-2
Memantine side effect was reported by a Physician from ARGENTINA on Sept 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blister, dehydration, dermatitis bullous, diabetes mellitus inadequate control, haematocrit decreased, haemoglobin decreased, hyperglycaemia, malaise, red blood cell count decreased. Memantine dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5635798-8
Memantine side effect was reported by a Health Professional from FRANCE on Feb 07, 2008. Female patient, 80 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: dizziness
, epilepsy , malaise. Memantine dosage: 20 MG,QD,PO. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4897081-8
Memantine side effect was reported by a Pharmacist from UNITED KINGDOM on Jan 18, 2006. Male patient, 76 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, malaise, myoclonus. Memantine dosage: 5 MG BID, PO. During the same period patient was treated with GALANTAMINE, SENNA. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5223588-X
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Jan 11, 2007. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, dysphasia, electroencephalogram abnormal, faecal incontinence, loss of consciousness, malaise, trismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.
Memantine Side Effects Report #5315159-1
Memantine side effect was reported by a Health Professional from ITALY on Apr 23, 2007. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aphasia
, convulsion, electrocardiogram abnormal, electroencephalogram abnormal, faecal incontinence, loss of consciousness, major depression, malaise, speech disorder. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.Memantine Side Effects Report #5190810-8
Memantine side effect was reported by a Pharmacist from ITALY on Oct 26, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anal sphincter atony, electrocardiogram st segment abnormal, electroencephalogram abnormal, loss of consciousness, malaise, trismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.
Memantine Side Effects Report #5519346-9
Memantine side effect was reported by a Health Professional from FRANCE on Oct 31, 2007. Female patient, 75 years of age, was diagnosed with dementia alzheimer's type, depression
and was treated with Memantine. After drug was administered, patient experienced the following side effects: bradycardia, malaise. Memantine dosage: 20 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient recovered.Memantine Side Effects Report #5650225-2
Memantine side effect was reported by a Consumer or non-health professional from CANADA on Feb 12, 2008. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: decreased appetite, fatigue, malaise, neoplasm malignant, pyrexia, red blood cell sedimentation rate increased, weight decreased. Memantine dosage: unknown. During the same period patient was treated with ARICEPT. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4615233-9
Memantine side effect was reported by a Consumer or non-health professional from on Mar 02, 2005. Female patient, 58 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, dyspnoea, fall
, gastrointestinal disorder, hypercholesterolaemia, malaise, resuscitation. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT, GALANTAMINE, CITALOPRAM HYDROBROMIDE, EUPHYTOSE, SMECTA. Patient died on 02/21/2003.Memantine Side Effects Report #4596749-0
Memantine side effect was reported by a Health Professional from on Jan 10, 2005. Male patient, 94 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: bradycardia, bundle branch block right, hypotension, malaise, pallor, syncope. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SALICYLATES. Patient recovered.
Memantine Side Effects Report #4557232-1
Memantine side effect was reported by a Consumer or non-health professional from on Jan 04, 2005. Female patient, 91 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: dyskinesia, malaise. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BUSPAR, CETORNAN, ARICEPT, TAREG, KARDEGIC, HAVLANE, CORDARONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #6108587-8
Memantine side effect was reported by a Health Professional from GERMANY on Feb 19, 2009. Male patient, 86 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: bradycardia, dyspnoea, electrocardiogram qt prolonged, hypertension, malaise, po2 decreased, renal failure. Memantine dosage: unknown. During the same period patient was treated with REMINYL, RISPERDAL, DEROXAT, FORLAX, LASIX, LOVENOX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #6127245-7
Memantine side effect was reported by a Pharmacist from GERMANY on Mar 04, 2009. Male patient, 86 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: bradycardia, dyspnoea, electrocardiogram qt prolonged, malaise, renal failure. Memantine dosage: unknown. During the same period patient was treated with REMINYL, RISPERDAL, DEROXAT, FORLAX, LASIX, LOVENOX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5826179-2
Memantine side effect was reported by a Health Professional from GERMANY on June 16, 2008. Female patient, 85 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: bundle branch block left, confusional state, loss of consciousness, malaise, orthostatic hypotension, urinary incontinence
. Memantine dosage: 20 MG (10 MG, 2 IN 1 D), ORAL. During the same period patient was treated with TENORMIN, TRIACTEC, MODOPAR, FOLIC ACID, TAHOR, ARIMIDEX. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5348503-X
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on May 22, 2007. Female patient, 78 years of age, weighting 99.21 lb, was treated with Memantine. After drug was administered, patient experienced the following side effects: aortic disorder, aortic stenosis, brain natriuretic peptide increased, malaise, orthostatic hypotension, pyelonephritis, sjogren's syndrome
. Memantine dosage: unknown. During the same period patient was treated with STABLON, ARICEPT, SECTRAL, RIFADIN, OFLOXACIN, MOPRAL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.